CuraScientific Corp
CSTF · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $230 | $441 | $0 | $0 |
| % Growth | -47.8% | – | – | – |
| Cost of Goods Sold | $796 | $220 | $154 | $154 |
| Gross Profit | -$566 | $222 | -$154 | -$154 |
| % Margin | -245.6% | 50.2% | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $300 | $1,014 | $147 | $495 |
| SG&A Expenses | $315 | $1,014 | $147 | $495 |
| Sales & Mktg Exp. | $15 | $0 | $0 | $0 |
| Other Operating Expenses | $5 | $43,875 | $3 | $0 |
| Operating Expenses | $320 | $1,294 | $301 | $649 |
| Operating Income | -$886 | -$2,347 | -$301 | -$649 |
| % Margin | -384.5% | -531.7% | – | – |
| Other Income/Exp. Net | -$4,831 | $43,622 | $84 | -$1,010 |
| Pre-Tax Income | -$5,716 | $41,275 | -$216 | -$1,658 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5,716 | $41,275 | -$216 | -$1,658 |
| % Margin | -2,482.5% | 9,351.4% | – | – |
| EPS | -0.008 | 0.39 | -0.032 | -0.25 |
| % Growth | -101.9% | 1,330.3% | 87.3% | – |
| EPS Diluted | -0.008 | 0.29 | -0.032 | -0.25 |
| Weighted Avg Shares Out | 756,677 | 105,966 | 6,818 | 6,659 |
| Weighted Avg Shares Out Dil | 756,677 | 142,439 | 6,818 | 6,659 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $155 | $34 | $7 | $7 |
| Depreciation & Amortization | $685 | $280 | $154 | $154 |
| EBITDA | -$4,877 | $41,589 | -$55 | -$1,497 |
| % Margin | -2,117.8% | 9,422.5% | – | – |